Specific Pharma A/s Sustainability Profile
Specific Pharma A/S, headquartered in Denmark (DK), is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of innovative drug delivery systems. Founded in [year], the company has established a strong presence in major operational regions across Europe and beyond, focusing on enhancing patient outcomes through advanced pharmaceutical solutions. With a commitment to quality and innovation, Specific Pharma A/S offers a range of unique products and services, including tailored formulations and cutting-edge delivery technologies. The company has achieved notable milestones, positioning itself as a trusted partner in the healthcare sector. Recognised for its expertise and dedication, Specific Pharma A/S continues to lead the way in providing effective and reliable pharmaceutical solutions, making significant contributions to the industry.
DitchCarbon Score
How does Specific Pharma A/s's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Specific Pharma A/s's score of 25 is lower than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Specific Pharma A/s, headquartered in Denmark (DK), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of PHOENIX Pharmahandel GmbH & Co KG, which may influence its climate commitments and performance metrics. As of now, Specific Pharma A/s has not established any documented reduction targets or climate pledges. The absence of specific initiatives or targets suggests that the company may be in the early stages of developing its climate strategy or is relying on the broader commitments of its parent organization. Given the lack of direct emissions data and reduction initiatives, it is essential for Specific Pharma A/s to consider aligning with industry standards and best practices in climate action, potentially drawing from the initiatives of PHOENIX Pharmahandel GmbH & Co KG, which operates at a higher cascade level. This alignment could enhance their sustainability profile and contribute to broader corporate climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 20,501,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 47,693,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 140,907,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | - | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
How Carbon Intensive is Specific Pharma A/s's Industry?
How Carbon Intensive is Specific Pharma A/s's Location?
Specific Pharma A/s's Scope 3 Categories Breakdown
Specific Pharma A/s's Scope 3 emissions, which decreased by 3% last year and increased significantly since 2015, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" representing nearly all of their reported Scope 3 footprint.
Top Scope 3 Categories
Specific Pharma A/s's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Specific Pharma A/s has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
